Clinical Efficacy of the Combined Effect of Oral Irrigator and Chemicals (0.075% CPC)

NCT ID: NCT06607172

Last Updated: 2024-12-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-30

Study Completion Date

2024-10-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an experimental gingivitis clinical study to evaluate gum health efficacy from the combination effect of water flosser and chemistry (0.075% CPC) compared to water flosser and water and to no oral hygiene regimen with a 3-week follow-up. Thirty participants, aged between 18 and 70, will be enrolled.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is an examiner blind, randomized controlled, parallel designed clinical study that aims to assess the gum health efficacy (antiplaque and antigingivitis) from the combination effect of water flosser and chemistry (0.075% CPC) compared to water flosser and water and to no oral hygiene in a 3-week experimental gingivitis. Thirty participants will be enrolled and allocated into 3 groups: group I - using a water flosser device and water each time; group II - using a water flosser device and dilutable chemistry product (0.075% CPC) after dilution each time (for groups I an II participants will use this regimen treatment twice daily, in the morning and evening, and no other oral hygiene will be allowed during the 21 days of follow-up); group III - negative control in which participants will abstain for any oral hygiene during the 21 days of follow-up. Gingival index measurements will be the primary efficacy variable after using the assigned regimen for 3 weeks for each subject. Subjects will under go baseline, 3 days, 1, 2 and 3 weeks visits. An Analysis of Covariance will be performed on the final or delta plaque scores using the baseline value as covariate. The F-test in this analysis will test the hypothesis that the waterflosser groups are equal in adjusted means.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Plaque Dental Plaque Induced Gingivitis Dental Plaque and Gingivitis Gingivitis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

dental hygiene products gingivitis dental plaque oral irrigator

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This is a randomized, controlled, examiner blind, parallel-group clinical trial
Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group II: waterflosser + dilutable 0.075% CPC

Subjects assigned to this group will use a water flosser device and dilutable chemistry product (0.075% CPC) after dilution each time. Water flosser must be used for one minute. They must use this regimen treatment twice daily (in the morning and evening). No other oral hygiene will be allowed during the 21 days of follow-up.

Group Type ACTIVE_COMPARATOR

oral irrigator

Intervention Type DEVICE

water flosser and 0.075% CPC

Cetylpyridinium Chloride (CPC)

Intervention Type DRUG

Cetylpyridinium 0.075%

Group III: negative control

Subjects assigned to this group will abstain for any oral hygiene during the 21 days of follow-up.

Group Type NO_INTERVENTION

No interventions assigned to this group

Group I: water flosser and water

Subjects assigned to this group will use a water flosser device and water each time. Water flosser must be used for one minute. They must use this regimen treatment twice daily (in the morning and evening). No other oral hygiene will be allowed during the 21 days of follow-up.

Group Type EXPERIMENTAL

oral irrigator

Intervention Type DEVICE

water flosser device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

oral irrigator

water flosser device

Intervention Type DEVICE

oral irrigator

water flosser and 0.075% CPC

Intervention Type DEVICE

Cetylpyridinium Chloride (CPC)

Cetylpyridinium 0.075%

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed informed consent form;
* Aged between 18 and 70;
* Available for the three (3) week study duration;
* Good general health for participation in the study, based on the opinion of the study investigator;
* Must have at least 20 natural permanent teeth;
* Teeth must meet the scoring entry criteria for dental plaque and gingivitis (gum inflammation) at the discretion of the study examiner.

Exclusion Criteria

* Medical condition which requires premedication prior to dental visits/procedures;
* Presence of fix/ removable prosthodontics dentures that may interfere with this study clinical examinations;
* Advanced periodontal disease (gum disease) and/or treatment for periodontal disease (including surgery) within the past twelve months;
* Five (5) or more decayed, untreated dental sites (cavities) and/or any dental condition requiring urgent dental care;
* Abnormalities/diseases of the soft or hard oral tissues;
* Orthodontic appliances/bands/lingual bars that interfere with any clinical assessment (plaque scoring)
* Use of drugs that can affect salivary flow;
* Use of antibiotics three (3) months prior to study entry and/or during participation in this study;
* Use of any over the counter medications other than analgesics that could interfere with the study at PI discretion;
* Self-reported pregnancy and/or breastfeeding;
* Current Participation in another clinical study or during the month prior to this clinical study entry;
* Known allergies and/or reactions to common dentifrice ingredients;
* Medical condition which prohibits not eating/drinking or chewing gum for four (4) hours prior to your scheduled visits;
* Immunocompromised conditions (AIDS, immunosuppressive drug therapy);
* Infectious disease and/or other blood borne diseases (Hepatitis series, HIV, tuberculosis).
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Federal University of Pelotas

OTHER

Sponsor Role collaborator

Colgate Palmolive

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wilker Muniz, PhD

Role: PRINCIPAL_INVESTIGATOR

Federal University of Pelotas

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Federal University of Pelotas

Pelotas, Rio Grande do Sul, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CRO 2024-06-WF-POC-BZ-CB

Identifier Type: -

Identifier Source: org_study_id